ChemoCentryx
CCXI
#3550
Rank
HK$29.08 B
Marketcap
HK$404.45
Share price
0.00%
Change (1 day)
33.71%
Change (1 year)

EPS for ChemoCentryx (CCXI)

EPS in 2022 (TTM): -HK$14.78

According to ChemoCentryx's latest financial reports the company's current EPS (TTM) is -HK$14.70. In 2021 the company made an earnings per share (EPS) of -HK$14.70 a decrease over its 2020 EPS that were of -HK$6.30.

EPS history for ChemoCentryx from 2012 to 2022

Annual EPS

Year EPS Change
2022 (TTM)-HK$14.780.49%
2021-HK$14.70133.33%
2020-HK$6.30-16.49%
2019-HK$7.5527.63%
2018-HK$5.91-305.41%
2017HK$2.88-142.53%
2016-HK$6.77-19.44%
2015-HK$8.40-0%
2014-HK$8.4013.68%
2013-HK$7.39-16.67%
2012-HK$8.87

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Biogen
BIIB
HK$85.50-681.48%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$10.52-171.53%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$27.97-290.26%๐Ÿ‡ฌ๐Ÿ‡ง UK
Bristol-Myers Squibb
BMY
HK$23.10-257.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$81.21-652.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$101.37-789.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$13.38-191.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$4.90-133.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Merck
MRK
HK$59.07-501.79%๐Ÿ‡บ๐Ÿ‡ธ USA